CMS opens NCD for beta-amyloid PET scans


The CMS launched a national coverage determination for Alzheimer's disease therapy directed by beta-amyloid PET scans results. SNMMI, which has called for mandating amyloid results to qualify for the new Alzheimer's disease treatment Aduhelm, said it is working with its Brain Imaging Council to provide comments on the proposal, "including the importance of covering beta-amyloid PET scans."

Full story:

SNMMI SmartBrief

Nuclear medicine, molecular imaging and therapy

Designed specifically for nuclear medicine and molecular imaging professionals, SNMMI SmartBrief is a FREE, daily e-mail newsletter. It provides the latest news and information to save you time and keep you informed on our profession.